Modelling the impact of varicella vaccination on varicella and zoster

Epidemiology and Infection

Volumn 138, Issue 4, 2010, Pages 469-481

  Karhunen, M ^a   Leino, T ^a   Salo, H ^a   Davidkin, I ^a   Kilpi, T ^a   Auranen, K ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Mathematical modelling; Vaccine preventable diseases; Vaccines; Varicella zoster

Indexed keywords

VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; FINLAND; HEALTH CENTER; HERPES ZOSTER; HUMAN; INFANT; MASS IMMUNIZATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NONHUMAN; PRIMARY HEALTH CARE; SEROLOGY; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; VIRUS TRANSMISSION; CHICKENPOX; COMPUTER SIMULATION; FEMALE; IMMUNOLOGY; INFORMATION PROCESSING; MALE; METHODOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; THEORETICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DATA COLLECTION; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, THEORETICAL; VACCINATION; YOUNG ADULT;

EID: 77949395252     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990768     Document Type: Article

References (24)

1. Seward JF, et al. Varicella vaccine effectiveness in the US vaccination program: a review. Journal of Infectious Diseases 2008; 197 (Suppl. 2) : S82-S89.
2. Kuter B, et al. Ten year follow-up of healthy children who recieved one or two injections of varicella vaccine. Pediatric Infectious Diseases Journal 2004; 23: 132-137.
3. Zhou F, et al. An economic analysis of the universal varicella vaccination program in the United States. Journal of Infectious Diseases 2008; 197 (Suppl. 2) : S156-S164.
4. Jumaan AO, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella. Journal of Infectious Diseases 2005; 191: 2002-2007.
5. Yih WK, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5: 68-72.
6. Ikada J, Kagami K, Yamamoto Y. Varicella may protect against zoster. Lancet 1973; 2: 1276.
7. Garnett GP, Ferguson NM. Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Reviews in Medical Virology 1996; 6: 151-161.
8. Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programmes on the incidence of chickenpox and shingles. Bulletin of Mathematical Biology 1999; 61: 1031-1064.
9. Brisson M, et al. Exposure to varicella boosts immunity to herpes-zoster : implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500-2507.
10. Gidding HF, et al. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australia and New Zealand Journal of Public Health 2005; 29: 544-551.
11. Goldman GS. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. Vaccine 2005; 23: 3349-3355.
12. Garnett GP, Grenfell BT. The epidemiology of varicella- zoster virus infections : the influence of varicella on the prevalence of herpes zoster. Epidemiology and Infection 1992; 108: 513-528.
13. Ferguson NM, Anderson RM, Garnett GP. Mass vaccination to control chickenpox: The influence of zoster. Proceedings of the National Academy of Sciences USA 1996; 93: 7231-7235.
14. Brisson M, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiology and Infection 2000; 125: 651-669.
15. Wallinga J, et al. Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries. Epidemiology and Infection 2001; 127: 281-295.
16. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. American Journal of Epidemiology 2006; 164: 936-944.
17. Nardone A, et al. The comparative seroepidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866-7872.
18. National Research and Development Centre for Walfare and Health (STAKES). Pilot data collection material for 2001-2003 concerning the reform of outpatient care statistics. Unpublished data, 2006.
19. Mossong J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 2008; 5: e74.
20. Anderson RM, May RM. Infectious Diseases of Humans - Dynamics and Control. Oxford: Oxford University Press, 1991.
21. Krause P, Klinman DM. Efficacy, immunogenecity, safety, and use of live attenuated chickenpox vaccine. Journal of Pediatrics 1995; 127: 518-525.
22. Edmunds W, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. Journal of Infection 2002; 44: 211-219.
23. Greenhalgh D, Dietz K. Some bounds on estimates for reproductive ratios derived from the age-specific force of infection. Mathematical Biosciences 1994; 124: 9-57.
24. Heymann DL (ed.). Control of Communicable Diseases Manual, 18th edn. Washington: American Public Health Association, 2004.